Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Admiral Share News (ADM)
ADM Share
Price
ADM Share
News
ADM Share
Chat
ADM Share
Trades2,376
ADM
Live RNS
ADM Share
Charts
ADM Level 2
Console
ADM Live
Share Price
ADM Broker
Ratings
ADM Directors
Deals
ADM Financial
Diary
ADM
Fundamentals
ADM Short
Positions
ADM
Media
ADM Company
Research
ADM Company
Timeline
Share Price Information for Admiral (ADM)
Last checked at -
Last checked at 
Intraday Admiral Share Chart
Wednesday broker round-up
Sirius Real Estate: Berenberg reiterates buy with a target price of 110p.
IG Design Group: Canaccord reiterates buy with a target price of 790p.
Bellway: Canaccord reiterates buy with a target price of 4,060p.
Glaxosmithkline: Liberum reiterates buy with a target price of 1,700p.
Bellway: Liberum reiterates buy with a target price of 4,200p.
Astrazeneca: Deutsche Bank reiterates buy with a target price of 10,200p.
Unilever: Deutsche Bank reiterates buy with a target price of 5,500p.
Barclays: JP Morgan reiterates overweight with a target price of 230p.
Clarkson: JP Morgan reiterates overweight with a target price of 4,110p.
SSP Group: Credit Suisse reiterates underperfom with a target price of 210p.
Admiral Group: Credit Suisse reiterates underperfom with a target price of 2,300p.
Latest ADM News
- WINNERS & LOSERS: WH Smith seeks capital, cuts outlook; Workspace down
4 days ago - UK dividends calendar - next 7 days
29 May 2026 - LONDON MARKET CLOSE: Stocks climb but BP knocked by sudden Chair exit
26 May 2026 - LONDON MARKET CLOSE: FTSE shrugs off political drama as oil price dips
14 May 2026 - WINNERS & LOSERS: 3i Group plummets; Spire jumps on takeover approach
14 May 2026 - WINNERS & LOSERS: Helios Towers raises outlook after "strong" quarter
7 May 2026 - UK dividends calendar - next 7 days
30 Apr 2026 - UK shareholder meetings calendar - next 7 days
22 Apr 2026
Related News
AstraZeneca says Truqap combination approved in US for prostate cancer
(Alliance News) - AstraZeneca PLC on Friday said a Truqap combination has been approved by the US Food & Drug Administration as a first and only targe...
LONDON MARKET CLOSE: FTSE soars on peace hope as SpaceX IPO blasts off
(Alliance News) - The FTSE 100 ended the week on the front foot as Iran claimed a deal with the US has "never been closer", while investors were glued...
LONDON MARKET MIDDAY: Shares rally as oil drops on Iran deal hopes
(Alliance News) - Stock prices in London were sharply higher at midday Friday, with airline stocks leading gains after reports of progress towards a d...
Admiral News
WINNERS & LOSERS: WH Smith seeks capital, cuts outlook; Workspace down
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Wednesday.
LONDON MARKET CLOSE: Stocks climb but BP knocked by sudden Chair exit
(Alliance News) - The FTSE 100 closed higher on Tuesday although a fall in oil major BP following the unexpected departure of Chair Albert Manifold li...
LONDON MARKET CLOSE: FTSE shrugs off political drama as oil price dips
(Alliance News) - The FTSE 100 closed higher on Thursday as ongoing political uncertainty was offset by encouraging UK GDP data, a cooling oil price a...
WINNERS & LOSERS: 3i Group plummets; Spire jumps on takeover approach
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday.
WINNERS & LOSERS: Helios Towers raises outlook after "strong" quarter
(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday.
Follow the stocks
